Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Tracey Buckley
Patients With High Levels of Circulating Endothelial Progenitor Cells (EPC) Following at Least Three Months of Anticoagulation for Unprovoked Venous Thromboembolism (VTE) Are at Low Risk of Recurrent VTE—Results From the ExACT Randomised Controlled Trial.
EClinicalMedicine
Medicine
Related publications
Protocol for a Systematic Review of Prognostic Models for the Recurrence of Venous Thromboembolism (VTE) Following Treatment for a First Unprovoked VTE
Systematic Reviews
Medicine
Costs of Venous Thromboembolism (Vte) Among Hospitalized Patients in China
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Incidence Rates, Clinical Profile, and Outcomes of Patients With Venous Thromboembolism. The Worcester VTE Study
Journal of Thrombosis and Thrombolysis
Cardiovascular Medicine
Hematology
Cardiology
Circulating Endothelial Cells in Patients With Venous Thromboembolism and Myeloproliferative Neoplasms
PLoS ONE
Multidisciplinary
Postoperative Venous Thromboembolism (VTE) in Patients Undergoing Endovenous Laser and Radiofrequency Ablation of the Saphenous Vein
The Journal of Japanese College of Angiology
Inferior Vena Cava Filters in Patients With Cancer and Venous Thromboembolism (VTE): Patterns of Use and Outcomes
Thrombosis Research
Hematology
A Risk Score for Prediction of Recurrence in Patients With Unprovoked Venous Thromboembolism (DAMOVES)
European Journal of Internal Medicine
Internal Medicine
Predicting the Risk of Venous Thromboembolism in Newly Diagnosed Myeloma With Immunomodulatory Drugs: External Validation of the IMPEDE VTE Score
American Journal of Hematology
Hematology
The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer Into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification
TH Open
